Intech Investment Management LLC Boosts Stock Position in Harrow, Inc. (NASDAQ:HROW)

Intech Investment Management LLC lifted its position in shares of Harrow, Inc. (NASDAQ:HROW) by 120.7% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 22,594 shares of the company’s stock after purchasing an additional 12,358 shares during the quarter. Intech Investment Management LLC’s holdings in Harrow were worth $758,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. State Street Corp grew its position in Harrow by 2.2% during the third quarter. State Street Corp now owns 730,973 shares of the company’s stock valued at $32,865,000 after acquiring an additional 15,554 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Harrow by 0.6% during the 3rd quarter. Geode Capital Management LLC now owns 722,730 shares of the company’s stock valued at $32,500,000 after purchasing an additional 3,960 shares during the last quarter. Braidwell LP raised its position in Harrow by 47.9% in the 3rd quarter. Braidwell LP now owns 439,638 shares of the company’s stock worth $19,766,000 after purchasing an additional 142,450 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in Harrow by 1.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 255,218 shares of the company’s stock worth $8,563,000 after purchasing an additional 3,589 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its position in Harrow by 443.1% during the third quarter. JPMorgan Chase & Co. now owns 238,367 shares of the company’s stock valued at $10,717,000 after buying an additional 194,480 shares during the period. 72.76% of the stock is owned by hedge funds and other institutional investors.

Harrow Price Performance

Shares of Harrow stock opened at $28.41 on Monday. The company’s fifty day simple moving average is $29.51 and its two-hundred day simple moving average is $38.38. Harrow, Inc. has a 12-month low of $9.86 and a 12-month high of $59.23. The firm has a market cap of $1.01 billion, a PE ratio of -30.22 and a beta of 0.69. The company has a quick ratio of 1.44, a current ratio of 1.55 and a debt-to-equity ratio of 3.23.

Wall Street Analyst Weigh In

Several research analysts have recently commented on HROW shares. HC Wainwright reiterated a “buy” rating and issued a $57.00 price objective on shares of Harrow in a report on Tuesday, March 18th. B. Riley decreased their price target on Harrow from $73.00 to $69.00 and set a “buy” rating on the stock in a research note on Wednesday, December 4th.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.